200-027 - CGM in Type 2 Diabetes - The Clinical Evidence
Online Course
•
Dexcom (UK) Distribution
About the CPD course
This course discusses a high-level overview of the existing evidence for using CGM in Type 2 diabetes. International clinical recommendations from ADA; AACE and EASD are examined where experts evaluated evidence to provide recommendations. Additionally; key systematic reviews; meta-analyses and clinical trials for CGM in Type 2 Diabetes are explored; including the landmark MOBILE study on the use of CGM in basal insulin users. Real-world evidence showing the benefits of CGM in this population is also discussed. The course concludes with a glance into the future and the need for continued evidence generation.
At Dexcom, we believe that with diabetes, knowledge is power, we’ve spent the last 20 years innovating and developing simpler and better ways for people with type 1 diabetes to measure, track and manage their diabetes. When Dexcom was established the only way to measure glucose levels was to fingerstick, it gave us a snapshot not a story which made it difficult to understand our glucose levels and trends over time or feel in control of our diabetes. Since then, we’ve launched the world’s first real-time CGM system and helped to eliminate more than 11 billion fingersticks.
